Stephanie Coward
Stephanie Coward
Verified email at ucalgary.ca
Title
Cited by
Cited by
Year
Effect of Oral Capsule–vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial
D Kao, B Roach, M Silva, P Beck, K Rioux, GG Kaplan, HJ Chang, ...
Jama 318 (20), 1985-1993, 2017
3362017
Past and future burden of inflammatory bowel diseases based on modeling of population-based data
S Coward, F Clement, EI Benchimol, CN Bernstein, JA Avina-Zubieta, ...
Gastroenterology 156 (5), 1345-1353. e4, 2019
1202019
Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis
JA King, J Jeong, FE Underwood, J Quan, N Panaccione, JW Windsor, ...
American Journal of Gastroenterology 115 (4), 507-525, 2020
572020
The impact of inflammatory bowel disease in Canada 2018: epidemiology
GG Kaplan, CN Bernstein, S Coward, A Bitton, SK Murthy, GC Nguyen, ...
Journal of the Canadian Association of Gastroenterology 2 (Supplement_1), S6-S16, 2019
522019
Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations
S Coward, L Leggett, GG Kaplan, F Clement
BMJ open 6 (9), e011821, 2016
462016
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis
S Coward, ME Kuenzig, G Hazlewood, F Clement, K McBrien, R Holmes, ...
Inflammatory bowel diseases 23 (3), 461-472, 2017
452017
Comparative effectiveness of mesalamine, sulfasalazine, corticosteroids, and budesonide for the induction of remission in Crohn's disease: a Bayesian network meta-analysis
S Coward, ME Kuenzig, G Hazlewood, F Clement, K McBrien, R Holmes, ...
Inflammatory bowel diseases 23 (3), 461-472, 2017
452017
Incidence of appendicitis over time: a comparative analysis of an administrative healthcare database and a pathology-proven appendicitis registry
S Coward, H Kareemi, F Clement, S Zimmer, E Dixon, CG Ball, ...
PloS one 11 (11), 2016
342016
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis
LE Leggett, LJJ Soril, S Coward, DL Lorenzetti, G MacKean, FM Clement
The primary care companion for CNS disorders 17 (6), 2015
342015
Living with Hepatitis C Virus: A Systematic Review and Narrative Synthesis of Qualitative Literature
LE Dowsett, S Coward, DL Lorenzetti, G MacKean, F Clement
Canadian Journal of Gastroenterology and Hepatology 2017, 2017
332017
Funding a smoking cessation program for Crohn˘s disease: an economic evaluation
S Coward, SJ Heitman, F Clement, M Negron, R Panaccione, S Ghosh, ...
The American journal of gastroenterology 110 (3), 368-377, 2015
302015
Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease
YPY Leung, GG Kaplan, S Coward, D Tanyingoh, BJ Kaplan, ...
Journal of Crohn's and Colitis 9 (3), 223-230, 2015
282015
The impact of inflammatory bowel disease in Canada 2018: a scientific report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn˘s and Colitis Canada
EI Benchimol, CN Bernstein, A Bitton, SK Murthy, GC Nguyen, K Lee, ...
Journal of the Canadian Association of Gastroenterology 2 (Supplement_1), S1-S5, 2019
252019
Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population–Based Analysis
LE Targownik, GG Kaplan, J Witt, CN Bernstein, H Singh, A Tennakoon, ...
American Journal of Gastroenterology 115 (1), 128-137, 2020
172020
A36 THE GLOBAL INCIDENCE OF PEPTIC ULCER DISEASE AND ITS COMPLICATIONS AT THE TURN OF THE 21ST CENTURY: A SYSTEMATIC REVIEW.
H Azhari, F Underwood, J King, S Coward, S Shah, S Ng, G Ho, C Chan, ...
Journal of the Canadian Association of Gastroenterology 1 (suppl_2), 61-62, 2018
16*2018
Ulcerative colitis-associated hospitalization costs: a population-based study
S Coward, SJ Heitman, F Clement, J Hubbard, MC Proulx, S Zimmer, ...
Canadian Journal of Gastroenterology and Hepatology 29 (7), 357-362, 2015
162015
The effect of initiation of anti-TNF therapy on the subsequent direct health care costs of inflammatory bowel disease
LE Targownik, EI Benchimol, J Witt, CN Bernstein, H Singh, L Lix, ...
Inflammatory Bowel Diseases 25 (10), 1718-1728, 2019
152019
Upfront combination therapy, compared with monotherapy, for patients not previously treated with a biologic agent associates with reduced risk of inflammatory bowel disease …
LE Targownik, EI Benchimol, CN Bernstein, H Singh, L Lix, A Tennakoon, ...
Clinical Gastroenterology and Hepatology 17 (9), 1788-1798. e2, 2019
152019
Combined biologic and immunomodulatory therapy is superior to monotherapy for decreasing the risk of inflammatory bowel disease-related complications
LE Targownik, EI Benchimol, CN Bernstein, H Singh, A Tennakoon, ...
Journal of Crohn's and Colitis 14 (10), 1354-1363, 2020
142020
hospital volume and other risk factors for in-hospital mortality among diverticulitis patients: a nationwide analysis
MJ Diamant, S Coward, WD Buie, A MacLean, E Dixon, CG Ball, ...
Canadian Journal of Gastroenterology and Hepatology 29 (4), 193-197, 2015
142015
The system can't perform the operation now. Try again later.
Articles 1–20